Paper41002155
Association of suPAR with progression of cardiovascular calcification and cardiovascular outcomes in peritoneal dialysis patients.
Guan J and 9 others. Ren Fail, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Association of suPAR with progression of cardiovascular calcification and cardiovascular outcomes in peritoneal dialysis patients. Papers, record 41002155. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41002155
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Association of suPAR with progression of cardiovascular calcification and cardiovascular outcomes in peritoneal dialysis patients.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Peritoneal Dialysis | Major topic |
| Receptors, Urokinase Plasminogen Activator | Major topic |
| Vascular Calcification | Major topic |
| Coronary Artery Disease | Major topic |
| Heart Valve Diseases | Major topic |
| Kidney Failure, Chronic | Major topic |
| Humans | |
| Male | |
| Female | |
| Middle Aged | |
| Disease Progression | |
| Aged | |
| Risk Factors | |
| Aorta, Abdominal | |
| Adult | |
| Cardiovascular Diseases |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19732942 | Haemostatic system, biochemical profiles, kynurenines and the prevalence of cardiovascular disease in peritoneally dialyzed patients. | Thromb Res | 2010 | https://conductscience.org/library/papers/19732942 | PubMed |
| 2 | 37195572 | Soluble urokinase plasminogen activator receptor is associated with cardiovascular calcification in peritoneal dialysis patients. | Int Urol Nephrol | 2024 | https://conductscience.org/library/papers/37195572 | PubMed |
| 3 | 26187601 | Hyperphosphatemia as an independent risk factor for coronary artery calcification progression in peritoneal dialysis patients. | BMC Nephrol | 2015 | https://conductscience.org/library/papers/26187601 | PubMed |
| 4 | 22909410 | Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score. | Int J Cardiol | 2013 | https://conductscience.org/library/papers/22909410 | PubMed |
| 5 | 2407762 | Quantification of coronary artery calcium using ultrafast computed tomography. | J Am Coll Cardiol | 1990 | https://conductscience.org/library/papers/2407762 | PubMed |
| 6 | 19414839 | A new equation to estimate glomerular filtration rate. | Ann Intern Med | 2009 | https://conductscience.org/library/papers/19414839 | PubMed |
| 7 | 37126347 | Progression of Vascular Calcification and Clinical Outcomes in Patients Receiving Maintenance Dialysis. | JAMA Netw Open | 2023 | https://conductscience.org/library/papers/37126347 | PubMed |
| 8 | 22459389 | CRP and suPAR are differently related to anthropometry and subclinical organ damage. | Int J Cardiol | 2013 | https://conductscience.org/library/papers/22459389 | PubMed |
| 9 | 23150653 | Soluble urokinase plasminogen activator receptor is associated with inflammation in the vulnerable human atherosclerotic plaque. | Stroke | 2012 | https://conductscience.org/library/papers/23150653 | PubMed |
| 10 | 31886242 | Association between Soluble Urokinase-Type Plasminogen Activator Receptor Levels and Chronic Kidney Disease: A Systematic Review and Meta-Analysis. | Biomed Res Int | 2019 | https://conductscience.org/library/papers/31886242 | PubMed |
| 11 | 36997664 | Transcription factor 21 accelerates vascular calcification in mice by activating the IL-6/STAT3 signaling pathway and the interplay between VSMCs and ECs. | Acta Pharmacol Sin | 2023 | https://conductscience.org/library/papers/36997664 | PubMed |
| 12 | 35106150 | Coronary artery calcification progression and long-term cardiovascular outcomes in renal transplant recipients: an analysis by the joint model. | Clin Kidney J | 2022 | https://conductscience.org/library/papers/35106150 | PubMed |
| 13 | 25222341 | Soluble urokinase plasminogen activator receptor is in contrast to high-sensitive C-reactive-protein associated with coronary artery calcifications in healthy middle-aged subjects. | Atherosclerosis | 2014 | https://conductscience.org/library/papers/25222341 | PubMed |
| 14 | 20027185 | Regulation of cell signalling by uPAR. | Nat Rev Mol Cell Biol | 2010 | https://conductscience.org/library/papers/20027185 | PubMed |
| 15 | 30197976 | Soluble Urokinase Plasminogen Activator Receptor (suPAR) and All-Cause and Cardiovascular Mortality in Diverse Hemodialysis Patients. | Kidney Int Rep | 2018 | https://conductscience.org/library/papers/30197976 | PubMed |
| 16 | 29672176 | Prevalence and risk factors for vascular calcification in Chinese patients receiving dialysis: baseline results from a prospective cohort study. | Curr Med Res Opin | 2018 | https://conductscience.org/library/papers/29672176 | PubMed |
| 17 | 36194491 | Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis. | J Clin Invest | 2022 | https://conductscience.org/library/papers/36194491 | PubMed |
| 18 | 24192237 | Urokinase receptor mediates osteogenic differentiation of mesenchymal stem cells and vascular calcification via the complement C5a receptor. | Stem Cells Dev | 2014 | https://conductscience.org/library/papers/24192237 | PubMed |
| 19 | 30675420 | KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). | Kidney Int Suppl (2011) | 2017 | https://conductscience.org/library/papers/30675420 | PubMed |
| 20 | 8738810 | Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis. | J Am Soc Nephrol | 1996 | https://conductscience.org/library/papers/8738810 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42663908 | Factors associated with vascular calcification in peritoneal dialysis patients: a meta-analysis. | Int Urol Nephrol | 2026 | https://conductscience.org/library/papers/42663908 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PLAUR | 5329 | PubTator's text mining | https://conductscience.org/library/genes/5329 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41002155
GET https://conductscience.org/api/papers/v1/41002155/references?page=2